Which sclerosing agent works best for vascular malformations?
NCT ID NCT07320430
First seen Jan 11, 2026 · Last updated May 01, 2026 · Updated 18 times
Summary
This study tested different sclerosing agents to treat low-flow vascular malformations (abnormal blood vessels) in 75 patients. The goal was to see which agent works best to shrink or remove the malformation and improve symptoms. The study is complete and focused on cure rates and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASCULAR MALFORMATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Faculty of medicine Ain Shams University
Cairo, Abbassia, 00202, Egypt
Conditions
Explore the condition pages connected to this study.